CHAMPIONSGATE, Fla., July 19, 2019 /PRNewswire/ -- Research published this week in the peer-reviewed Journal of Occupational Medicine and Toxicology (JOMT) shows that the safety thresholds for mercury exposure can be exceeded during dental procedures involving drilling on amalgam fillings if special precautions are not in place, according to the International Academy of Oral Medicine and Toxicolo

SUNNYVALE, Calif., July 19, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2019 ended June 30, 2019 on Thursday, August 15, 2019 after the market close. Management will host a conference call to review the results at

DUBLIN, July 19, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that its Board of Directors has declared a cash dividend of $0.74 per ordinary share for the third quarter of 2019. The dividend will be paid on September 13, 2019 to shareholders of record at the close of business on

SAN DIEGO, July 19, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that Janssen-Cilag International NV (Janssen) has submitted an extension application to the European Medicines Agency (EMA) for the subcutaneous delivery of DARZALEX® (daratumuma

SAN JOSE, Calif., July 19, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation to AR-501, the Company's inhaled formulation of gallium citrate for treatment of lung infection in patients with cystic fibrosis. This past June, Aridis also received Orphan Dr

MIAMI BEACH, Fla., July 19, 2019 /PRNewswire/ -- The next frontier in ischemic stroke therapy, advances in stenting, and innovations in cerebrospinal fluid imaging and diagnostics are a few of the topics that will be covered at the Society of NeuroInterventional Surgery's (SNIS) 16th Annual Meeting in Miami Beach from July 22–2

STOCKHOLM, July 19, 2019 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, today announced that the company has signed an agreement with EGeen Inc., a clinical research organization (CRO), for conducting its upcoming clinical phase IIb trial with Rabeximod in rheumatoid arthritis (RA) in select Eastern European countries. Cyxone is now, together

VILNIUS, Lithuania, July 19, 2019 /PRNewswire/ -- Northway Biotechpharma, a leading biopharmaceutical contract development and manufacturing organization (CDMO), celebrates its 15th anniversary today. As a midsized CDMO, Northway Biotechpharma is able to provide flexibility and responsiveness backed by a strong foundation in science and technology. The company

THOUSAND OAKS, Calif., July 18, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a biosimilar to Herceptin® (trastuzumab), are now available in the Unit

INCHEON, South Korea and HONG KONG, July 18, 2019 /PRNewswire/ -- Celltrion and Nan Fung Group announced today the establishment of Vcell Healthcare Limited, a Joint Venture company between both parties.At the formation of the Joint Venture, Vcell Healthcare Limited has simultaneously signed a licensing agreement with Celltrio